Email not displaying correctly? View it in your browser


Publication: Nature Outlook Supplement on Chagas Disease

Chagas disease is one of the most neglected diseases. In all, 8 million people are infected around the globe - the vast majority of them living in Latin America. Nature Outlook dedicates an entire issue to this deadly disease: "Chagas disease: A new era of hope for this neglected disease".         
Read more

New Potential TB Drugs to be Investigated Against Multiple Neglected Diseases: A Unique Collaboration between TB Alliance and DNDi

The Global Alliance for TB Drug Development (TB Alliance) and Drugs for Neglected Diseases initiative (DNDi) announced a unique first-ever royalty-free license agreement between two not-for-profit drug developers that speeds progress toward improved therapy options for several neglected diseases.
Read more

Event: ICOPA XII, August 15 - 20, 2010, Melbourne

DNDi will be organising 2 symposia at ICOPA, one on Malaria and one on Drug Discovery. DNDi will also hold a preview of the documentary "1$ for 1 life".
Read more

US$ 1.5 Grant from the Bill & Melinda Gates Foundation

The Bill & Melinda Gates Foundation granted US$ 1.5 million for the preclinical assessment of a new drug candidate (from the nitroimidazole class) for visceral leishmaniasis.
Read more

Advocacy for R&D in US

DNDi North America has been raising awareness among U.S. Congress members, national health leaders, and pharmaceutical companies about the need for greater R&D for neglected tropical diseases.
Read more